SEC Comment Letter for RENOVARO INC. (RENB) (CIK 0001527728) (LNAI) — Apr 10, 2020
RENOVARO INC. (RENB) (CIK 0001527728)
Date: April 10, 2020 · CIK: 0001527728 · Accession: 0000000000-20-003118
AI Filing Summary & Sentiment
File numbers found in text: 001-38758
Letter
April 10, 2020 Mark Dybul Executive Vice Chair Enochian Biosciences Inc 2080 Century Park East, Suite 906 Los Angeles, CA 90067 Re:Enochian Biosciences Inc Form 10-K for the fiscal year ended June 30, 2019 Filed September 30, 2019 File No. 001-38758 Dear Mr. Dybul: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
April 10, 2020
Mark Dybul
Executive Vice Chair
Enochian Biosciences Inc
2080 Century Park East, Suite 906
Los Angeles, CA 90067
Re:Enochian Biosciences Inc
Form 10-K for the fiscal year ended June 30, 2019
Filed September 30, 2019
File No. 001-38758
Dear Mr. Dybul:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences